Not finding it? Sign in to also search OpenAlex live.
-
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation2022 Journal of Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
Janine E. Melsen, Monique M. van Ostaijen-ten Dam, Erik B. van den Akker, Marij J.P. Welters, Kim C. Heezen, Ingrid Pico‐Knijnenburg, +6 more
7citations -
Oocyte donation pregnancies with high fetal-maternal immunogenetic dissimilarity show alterations in the maternal peripheral immunoregulatory response2024 Journal of Reproductive Immunology article Immunology and Microbiology Reproductive System and Pregnancy Open access
Kim van Bentem, Lotte J. Verleng, Géraldine Lafeber, Xinping Tian, E. van Beelen, Carin van der Keur, +4 more
3citations -
Mass cytometry data integration methods reveal rural-urban gradient of immune profiles across geography2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Single-cell and spatial transcriptomics
Koen A. Stam, Jeremia Jackson Pyuza, Mikhael D. Manurung, Dicky L. Tahapary, Taniawati Supali, Marloes M.A.R. van Dorst, +5 more
2citations -
Dysfunctional CD4 T cells in an oncovirus-specific TCR-transgenic in vivo model2025 Nature Communications article Immunology and Microbiology T-cell and B-cell Immunology Open access
Felicia S. Spitzer, Marcel G M Camps, Cedrik Michael Britten, Sandra A. Vloemans, Hester J.T. van Zeeburg, Cornelis J.M. Melief, +2 more
0citations -
Divergent CD27 expression marks the Treg induction trajectory2026 Frontiers in Immunology article Immunology and Microbiology T-cell and B-cell Immunology Open access
Chelsea Gootjes, Maurits G. Staal, Diahann T. S. L. Jansen, Antoinette M. Joosten, Jaap Jan Zwaginga, Bart O. Roep, +1 more
0citations -
689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-22023 Regular and Young Investigator Award Abstracts conference-abstract Medicine Multiple Myeloma Research and Treatments Open access
Deeksha Vishwamitra, Sheri Skerget, M. Damiette Smit, Lien Vandenberk, Kalpana K. Bakshi, Sangmin Lee, +7 more
0citations -
Baseline memory B-cell enrichment and heightened B-cell activation are associated with irAEs2026 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access
Sarah Soussan, Amel Ait Ahcene, Lucie Garnier, Lou Lelievre, Sofiene Tifoura, Magali Fradet, +12 more
0citations -
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division2021 International Journal of Cancer article Immunology and Microbiology Immune Cell Function and Interaction Open access cited by 2 patents
Linda Borst, Marjolein Sluijter, Gregor Sturm, Pornpimol Charoentong, Saskia J A M Santegoets, Mandy van Gulijk, +8 more
58citations -
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancers2025 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer-related gene regulation Open access
M.M. Gounder, Patricia Martín-Romano, Antoîne Italiano, L. L. Siu, Philippe Alexandre Cassier, Gerald Steven Falchook, +15 more
22citations -
Abstract CT286: TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanoma
Sajeve Samuel Thomas, Young Ki Hong, Yazan Samhouri, James Larkin, Gino Kim In, Victoria G. Atkinson, +21 more
2citations -
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma2022 Journal of Experimental & Clinical Cancer Research article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Dong Liu, Lara Rosaline Heij, Zoltán Czigány, Edgar Dahl, Sven Arke Lang, Tom Florian Ulmer, +3 more
127citations -
The NADINA trial: A multicenter, randomised, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Minke W. Lucas, J. Lijnsvelt, Saskia M. Pulleman, Richard A. Scolyer, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, +13 more
47citations